Heartland Bank & Trust Co purchased a new position in The Allstate Corporation (NYSE:ALL – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 3,333 shares of the insurance provider’s stock, valued at approximately $793,000.
Several other institutional investors and hedge funds also recently made changes to their positions in ALL. MV Capital Management Inc. bought a new stake in shares of Allstate in the fourth quarter valued at about $25,000. Gables Capital Management Inc. bought a new position in Allstate during the second quarter valued at about $26,000. Navalign LLC acquired a new position in Allstate in the 4th quarter valued at approximately $27,000. Kelleher Financial Advisors acquired a new position in Allstate in the 2nd quarter valued at approximately $28,000. Finally, Evolution Wealth Management Inc. lifted its position in shares of Allstate by 7,000.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock worth $29,000 after acquiring an additional 140 shares during the period. Institutional investors own 76.47% of the company’s stock.
Allstate Price Performance
Shares of Allstate stock opened at $253.82 on Friday. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24. The stock has a market capitalization of $64.18 billion, a price-to-earnings ratio of 5.07, a P/E/G ratio of 0.39 and a beta of 0.16. The Allstate Corporation has a 1-year low of $188.08 and a 1-year high of $277.22. The firm’s 50-day moving average price is $250.34 and its two-hundred day moving average price is $224.95.
Allstate Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be issued a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Monday, August 31st. Allstate’s dividend payout ratio (DPR) is currently 8.63%.
Wall Street Analysts Forecast Growth
ALL has been the topic of several recent research reports. JPMorgan Chase & Co. lifted their price objective on Allstate from $282.00 to $292.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. Citigroup cut Allstate from a “neutral” rating to a “sell” rating and raised their target price for the stock from $226.00 to $240.00 in a research report on Tuesday, August 11th. Cantor Fitzgerald lifted their price target on shares of Allstate from $236.00 to $242.00 and gave the stock a “neutral” rating in a research note on Thursday, July 9th. Morgan Stanley set a $265.00 price objective on shares of Allstate in a report on Tuesday, August 11th. Finally, HSBC lowered shares of Allstate from a “buy” rating to a “hold” rating and lifted their target price for the company from $244.00 to $264.00 in a research report on Monday, July 6th. Four equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, eight have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $265.26.
Read Our Latest Analysis on Allstate
Insider Buying and Selling at Allstate
In other news, insider John E. Dugenske sold 32,996 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the sale, the insider owned 13,054 shares in the company, valued at approximately $3,515,833.82. This represents a 71.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrea Redmond sold 2,225 shares of the firm’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the sale, the director owned 2,225 shares of the company’s stock, valued at approximately $451,474.75. This trade represents a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 91,446 shares of company stock worth $24,208,675. 1.55% of the stock is currently owned by insiders.
Trending Headlines about Allstate
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
- Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
- Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
- Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
- Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
- Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates
About Allstate
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Recommended Stories
- Five stocks we like better than Allstate
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
